Table 5.
Cardiovascular mortality by cancer characteristics in patients with prior cancer.
| In-Hospital Cardiovascular Mortality, n (%) | p Value | 1-Year Cardiovascular Mortality, n (%) | p-Value | |
|---|---|---|---|---|
| * Cancer AJCC staging | 0.175 | 0.45 | ||
| I | 26 (6.9) | 29 (7.7) | ||
| II | 16 (4.4) | 22 (6.1) | ||
| III | 11 (3.5) | 17 (5.4) | ||
| IV | 16 (4.5) | 18 (5.1) | ||
| † Duration from cancer diagnosis | 0.050 | 0.025 | ||
| 1st quartile | 19 (3.1) | 26 (4.2) | ||
| 2nd quartile | 38 (6.2) | 49 (7.9) | ||
| 3rd quartile | 37 (6.0) | 49 (7.9) | ||
| 4th quartile | 35 (5.7) | 46 (7.5) | ||
| ‡ Cancer treatment | ||||
| Radiotherapy | 17 (4.9) | 0.806 | 22 (6.3) | 0.73 |
| No radiotherapy | 80 (5.2) | 105 (6.9) | ||
| Chemotherapy | 23 (4.5) | 0.415 | 33 (6.4) | 0.73 |
| No chemotherapy | 74 (5.4) | 94 (6.9) | ||
| Hormone therapy | 12 (4.5) | 0.594 | 12 (4.5) | 0.11 |
| No hormone therapy | 85 (5.3) | 115 (7.1) | ||
| Biological therapy | 3 (3.2) | 0.365 | 3 (3.2) | 0.15 |
| No biological therapy | 94 (5.3) | 124 (7.0) | ||
| At least one of the four therapies | 40 (4.6) | 0.320 | 54 (6.2) | 0.40 |
| None of the four therapies | 57 (5.6) | 73 (7.2) |
Abbreviations: AJCC: American Joint Committee on Cancer; IQR: interquartile range. * Data on cancer staging are only available for cancer cases diagnosed from 2003 onwards. † Quartiles: 0–425 days, 426–1911 days, 1912–4820 days, >4820 days. ‡ Limited to treatment received within the first 6 months from cancer diagnosis and data on treatment are only available for cancer cases diagnosed from 2003 onwards.